These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17265473)

  • 1. "Resurrection of thrombin" in the pathophysiology of the antiphospholipid syndrome.
    Koike T; Atsumi T
    Arthritis Rheum; 2007 Feb; 56(2):393-4. PubMed ID: 17265473
    [No Abstract]   [Full Text] [Related]  

  • 2. Beta2-glycoprotein I binds thrombin via exosite I and exosite II: anti-beta2-glycoprotein I antibodies potentiate the inhibitory effect of beta2-glycoprotein I on thrombin-mediated factor XIa generation.
    Rahgozar S; Yang Q; Giannakopoulos B; Yan X; Miyakis S; Krilis SA
    Arthritis Rheum; 2007 Feb; 56(2):605-13. PubMed ID: 17265495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelets and the antiphospholipid syndrome.
    Urbanus RT; Derksen RH; de Groot PG
    Lupus; 2008 Oct; 17(10):888-94. PubMed ID: 18827053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current insight into diagnostics and pathophysiology of the antiphospolipid syndrome.
    Urbanus RT; Derksen RH; de Groot PG
    Blood Rev; 2008 Mar; 22(2):93-105. PubMed ID: 17964017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology of antiphospholipid antibodies.
    de Groot PG; Derksen RH
    Neth J Med; 2004 Sep; 62(8):267-72. PubMed ID: 15588066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms.
    Pierangeli SS; Chen PP; Raschi E; Scurati S; Grossi C; Borghi MO; Palomo I; Harris EN; Meroni PL
    Semin Thromb Hemost; 2008 Apr; 34(3):236-50. PubMed ID: 18720303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some antiphospholipid antibodies bind to various serine proteases in hemostasis and tip the balance toward hypercoagulant states.
    Chen PP; Wu M; Hahn BH
    Lupus; 2010 Apr; 19(4):365-9. PubMed ID: 20353971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiphospholipid antibodies and the protein C pathway.
    Urbanus RT; de Laat B
    Lupus; 2010 Apr; 19(4):394-9. PubMed ID: 20353976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prothrombotic mechanisms based on the impairment of fibrinolysis in the antiphospholipid syndrome.
    Forastiero R; Martinuzzo M
    Lupus; 2008 Oct; 17(10):872-7. PubMed ID: 18827051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiphospholipid antibody syndrome and autoimmune diseases.
    Ostrowski RA; Robinson JA
    Hematol Oncol Clin North Am; 2008 Feb; 22(1):53-65, vi. PubMed ID: 18207065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Beta2 glycoprotein-I--the main antigen in antiphospholipid syndrome].
    Musiał J
    Pol Arch Med Wewn; 2007; 117 Suppl():59-60. PubMed ID: 18778023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of LRP8 (ApoER2') in the pathophysiology of the antiphospholipid syndrome.
    de Groot PG; Derksen RH; Urbanus RT
    Lupus; 2010 Apr; 19(4):389-93. PubMed ID: 20353975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel considerations in the pathogenesis of the antiphospholipid syndrome: involvement of the tissue factor pathway of blood coagulation.
    Adams M
    Semin Thromb Hemost; 2008 Apr; 34(3):251-5. PubMed ID: 18720304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiphospholipid antibodies and the antiphospholipid syndrome: clinical significance and treatment.
    Asherson RA; Cervera R; Merrill JT; Erkan D
    Semin Thromb Hemost; 2008 Apr; 34(3):256-66. PubMed ID: 18720305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibody explosion in antiphospholipid syndrome.
    Shoenfeld Y; Twig G; Katz U; Sherer Y
    J Autoimmun; 2008; 30(1-2):74-83. PubMed ID: 18171610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of platelet activation on the hypercoagulability induced by murine monoclonal antiphospholipid antibodies.
    Membre A; Wahl D; Latger-Cannard V; Max JP; Lacolley P; Lecompte T; Regnault V
    Haematologica; 2008 Apr; 93(4):566-73. PubMed ID: 18322249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous thrombosis in the antiphospholipid syndrome.
    Farmer-Boatwright MK; Roubey RA
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):321-5. PubMed ID: 19228605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinguished effects of antiphospholipid antibodies and anti-oxidized LDL antibodies on oxidized LDL uptake by macrophages.
    Kobayashi K; Tada K; Itabe H; Ueno T; Liu PH; Tsutsumi A; Kuwana M; Yasuda T; Shoenfeld Y; de Groot PG; Matsuura E
    Lupus; 2007; 16(12):929-38. PubMed ID: 18042586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial activation by aPL: a potential pathogenetic mechanism for the clinical manifestations of the syndrome.
    Meroni PL; Raschi E; Camera M; Testoni C; Nicoletti F; Tincani A; Khamashta MA; Balestrieri G; Tremoli E; Hess DC
    J Autoimmun; 2000 Sep; 15(2):237-40. PubMed ID: 10968917
    [No Abstract]   [Full Text] [Related]  

  • 20. [Physiopathology of the antiphospholipid syndrome].
    Pasquali JL
    Rev Med Interne; 2007 Dec; 28 Suppl 4():S302-3. PubMed ID: 17964695
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.